Menu
Washingtoner
  • Home
  • Health
  • Books
  • Business
  • Technology
  • Lifestyle
  • Aerospace
  • Financial
  • Artificial Intelligence
Washingtoner

Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

Trending...
  • Tacoma Dome Welcomes Class of 2026
  • From Broken to Soaring Week 40
  • CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
Laboratory Testing for Product Validation BSR Labs Juventix PRP Study Table Juventix Packaging With Tubes Juventix Regenerative Medical, LLC
TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:
  • 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
  • 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
  • Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
  • Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
  • Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.
"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner
  • Tacoma: City Council Adopts Updated Stormwater Management Manual to Enhance Environmental Health and Regulatory Compliance
  • Spokane Police Sergeant Pulls Elderly Female from Burning Home
  • What Would you Do with Your Time if it Was Actually Money?
  • Mr. Hospital Bed Showcases the Best Hospital Bed and Air Mattress for Bed Sores for 2026
  • City of Tacoma Presents Updated Financial Forecast as Next Step in 'Roadmap to Recovery' to Navigate National Economic Pressures

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner
  • Tacoma: Full Intersection Closure at E. 11th Street and St. Paul Avenue for One-Day Asphalt Repairs on June 27
  • Spokane: Early-Morning House Fire Damages Two Homes on East Sanson Avenue
  • Spokane City Council Passes Aggressive Speeding Ordinance
  • Traian TKD Tractari Auto Iasi: cum transporti legal la RAR o masina fara numere sau cu ITP expirat
  • Republican National Hispanic Assembly & Metropolitan Republican Club Announce Strategic Partnership

✉️ Email:
hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.

Media Contact
Lance Liberti
***@juventix.com
866-693-4777


Source: Juventix Regenerative Medical, LLC

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Super Lawyers Recognizes Inman & Tourgee Attorneys Mark Tourgee and Jacob Rinn
  • PropAccount.com Launches PropGenie, the First Branding Studio Built for Prop Firm Operators
  • Rushing Headlong: Health IT's Legacy and the Road to Responsible AI is named 2025 Foreword INDIES Book of the Year Awards Winner
  • Washington State High School Students Launch Virtual Rocketry Summit
  • The Problem With AI Isn't Compute. It's Memory
  • Golden Visa Countries Outpace Eurozone Growth Over Eight Years, New La Vida Analysis Finds
  • Allstream Energy Partners Announced as Official Media Partner for the 2nd Annual Permian Power Conference
  • ATTENTION: DGCA India & CAAC China — Boeing Quality Chief Doug Ackerman Linked To 24 Year Unaccredited Manufacturing Gap Ahead Of 787 Failures
  • City of Tacoma to Implement Temporary Road Closures and Traffic Restrictions on June 12
  • Spokane: Notice from SPD as Team Egypt Arrives & FIFA Events Begin
  • Spokane: Significant Impacts to North-South Travel
  • CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
  • Boston Industrial Solutions Introduces New Natron® 310 Hyper White UV Ink for Enhanced Printing Performance
  • New Tribute Song Celebrating Seattle'
  • New analysis reveals second job workers keep just 80p in every pound they earn
  • NRE Health Institute Launches International Study Examining Motivations Behind Non-Sexual Nudity
  • A Foundational Claim in Human Secrecy Goes Public
  • Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
  • Las Vegas Headliner Don Barnhart Brings National Touring Comedy Show to Comedy Cabana
  • Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
_catLbl0 _catLbl1

Popular on Washingtoner

  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan - 225
  • KLEKT Announces Appointment of Jay Kimpton to Board of Directors
  • Collectibles EvoRelic Celebrates Stellar 4.8-Star Customer Rating
  • Spokane: Flags Lowered for Peace Officers Memorial Day
  • iatroX surpasses 500,000 clinical queries and expands specialist exam coverage
  • Tacoma: City Manager Hyun Kim to Present ‘Roadmap to Recovery’ on May 12
  • The Simplest Small Business You're Probably Not Thinking About
  • All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
  • American Mensa and Davidson Institute Join Forces To Strengthen Support for Profoundly Gifted Youth
  • From Blank Page to Published Book

Similar on Washingtoner

  • Record Revenue Growth, AI-Driven Healthcare Innovation, Expanding Proprietary Brand and Targeting $200 Million Revenue By 2029: Cosmos Health Inc
  • Mr. Hospital Bed Showcases the Best Hospital Bed and Air Mattress for Bed Sores for 2026
  • Longevityresearch.ca Unveils a Unique Bayesian Causal Atlas; Saves up to 7.9 life years/patient
  • School Dental Screening Programs Conducted in Dubai
  • Rushing Headlong: Health IT's Legacy and the Road to Responsible AI is named 2025 Foreword INDIES Book of the Year Awards Winner
  • The Problem With AI Isn't Compute. It's Memory
  • CCHR Calls Out Psychiatry's Pattern of Resistance to Antidepressant Deprescribing
  • NRE Health Institute Launches International Study Examining Motivations Behind Non-Sexual Nudity
  • Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute